deckeln ist angesagt/GrB
Top-News
Explosionsgefahr bei NEUROMETRIX
Beiträge:
10
Zugriffe: 6.155 / Heute: 2
Zugriffe: 6.155 / Heute: 2
|
Werbung
Entdecke die beliebtesten ETFs von Xtrackers
Xtrackers LevDAX Daily Swap UCITS ETF 1C
Perf. 12M: +52,95%
Xtrackers MSCI Pakistan Swap UCITS ETF 1C
Perf. 12M: +37,93%
Xtrackers MSCI Europe Financials Screened UCITS ETF 1C
Perf. 12M: +32,00%
Xtrackers MSCI Europe Commun. Services Scr. UCITS ETF 1C
Perf. 12M: +28,83%
Xtrackers Spain UCITS ETF 1D
Perf. 12M: +28,35%
War der nicht im Zuchthaus der Thämann?Sitzt der noch?
nicht schlecht was geht an Interessaenten*grinz*
NeuroMetrix is a science-based company advancing patient care through the development and marketing of innovative medical devices and products that aid physicians in the assessment and treatment of diseases and injuries of peripheral nerves, and that provide regional anesthesia and pain control.
Founded in 1996 and emerging from the Harvard-MIT Division of Health Sciences and Technology, the company’s mission is to:
Create value for our customers by developing innovative neurotechnologies that maximize quality of care
Produce a competitive return on investment for our shareholders
Provide our employees with an opportunity for growth so that they may realize their professional potential
The company is accomplishing these goals by utilizing its core competencies in neurophysiology, biomedical engineering, and information technology.
www.neurometrix.com/about-us-company-overview.htm
Founded in 1996 and emerging from the Harvard-MIT Division of Health Sciences and Technology, the company’s mission is to:
Create value for our customers by developing innovative neurotechnologies that maximize quality of care
Produce a competitive return on investment for our shareholders
Provide our employees with an opportunity for growth so that they may realize their professional potential
The company is accomplishing these goals by utilizing its core competencies in neurophysiology, biomedical engineering, and information technology.
www.neurometrix.com/about-us-company-overview.htm
to Exhibit at The Endocrine Society Annual Meeting "ENDO 2011"
Preview for New Product Targeted at Diabetes Market
WALTHAM, Mass., Jun 01, 2011 (BUSINESS WIRE) --
NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it will exhibit at the annual meeting of The Endocrine Society in Boston on June 4-6, 2011. The exhibition will include a demonstration of its newest product - NC-stat(R)|DPNCheck(TM) which is a fast, accurate, and quantitative test for the evaluation of systemic neuropathies such as diabetic peripheral neuropathy (DPN).
NC-stat DPNCheck Benefits
May aid in the early detection, confirmation, and monitoring of DPN
Measures sural nerve conduction velocity - a standard biomarker for subclinical and symptomatic DPN
Sensitive and specific for DPN1,2, and predictive of its complications3
Straightforward clinical interpretation
Cost effective
"We are excited to preview NC-stat DPNCheck at ENDO 2011 as it a key milestone in our aggressive timetable to launch this product into the diabetes market," said Shai N. Gozani M.D., PhD., President and Chief Executive Officer of NeuroMetrix. "This point-of-care device should help address the need for a widely available, objective and standardized test for diabetic neuropathy."
NeuroMetrix encourages ENDO 2011 attendees to stop by booth #833-835 to:
Learn more about NC-stat DPNCheck.
View a live demonstration.
Inquire about a no-obligation evaluation.
Meet with NeuroMetrix representatives.
Preview for New Product Targeted at Diabetes Market
WALTHAM, Mass., Jun 01, 2011 (BUSINESS WIRE) --
NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it will exhibit at the annual meeting of The Endocrine Society in Boston on June 4-6, 2011. The exhibition will include a demonstration of its newest product - NC-stat(R)|DPNCheck(TM) which is a fast, accurate, and quantitative test for the evaluation of systemic neuropathies such as diabetic peripheral neuropathy (DPN).
NC-stat DPNCheck Benefits
May aid in the early detection, confirmation, and monitoring of DPN
Measures sural nerve conduction velocity - a standard biomarker for subclinical and symptomatic DPN
Sensitive and specific for DPN1,2, and predictive of its complications3
Straightforward clinical interpretation
Cost effective
"We are excited to preview NC-stat DPNCheck at ENDO 2011 as it a key milestone in our aggressive timetable to launch this product into the diabetes market," said Shai N. Gozani M.D., PhD., President and Chief Executive Officer of NeuroMetrix. "This point-of-care device should help address the need for a widely available, objective and standardized test for diabetic neuropathy."
NeuroMetrix encourages ENDO 2011 attendees to stop by booth #833-835 to:
Learn more about NC-stat DPNCheck.
View a live demonstration.
Inquire about a no-obligation evaluation.
Meet with NeuroMetrix representatives.
Text zur Anzeige gekürzt. Gesamten Beitrag anzeigen »
NURO (Common Stock)
Exchange NASDAQ (US Dollar)
Price $0.45
Change (%) 0.01 (2.17%)
Volume 100
Today's Open $0.00
Previous Close $0.46
Intraday High $0.00
Intraday Low $0.45
52 Week High $1.35
52 Week Low $0.41
Data as of 06/02/11 9:32 a.m. ET
Minimum 20 minute delay - Refresh quote
phx.corporate-ir.net/...x.zhtml?c=180007&p=irol-stockquote
Exchange NASDAQ (US Dollar)
Price $0.45
Change (%) 0.01 (2.17%)
Volume 100
Today's Open $0.00
Previous Close $0.46
Intraday High $0.00
Intraday Low $0.45
52 Week High $1.35
52 Week Low $0.41
Data as of 06/02/11 9:32 a.m. ET
Minimum 20 minute delay - Refresh quote
phx.corporate-ir.net/...x.zhtml?c=180007&p=irol-stockquote
Anzeige: Antimon-Alarm
NevGold, Perpetua und UAMY entfesseln den US-Kampf um kritische Rohstoffe
kein aktueller Kurs verfügbar ,GrB
Es gibt keine neuen Beiträge.
NewsFlash Uranexplorer startet geologische Großoffensive – Kursverdopplung am Donnerstag? Anzeige
Ich:
Neueste Beiträge aus dem NeuroMetrix Inc Forum
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 15 | neurometrix....top oder flop | buran | Comeback_2021 | 30.08.21 09:36 | ||
| 6 | NeuroMetrix, Inc. (NURO) | Chalifmann3 | HiGhLiFE | 25.04.21 00:29 | ||
| 9 | Explosionsgefahr bei NEUROMETRIX | buran | buran | 24.04.21 23:20 | ||
| 4 | Neurometrix explodiert. | Iceage123 | Iceage123 | 26.06.13 17:40 |